FDA clears Clario's SpiroSphere® with wireless ECG, streamlining data collection in clinical trials

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Clario-ECG-FDA

More Like This

PR Newswire associated0

Clario's New AI-Powered ECG Quality Score Tool Enhances Cardiac Safety Assessments

PR Newswire associated0

Clario delivers substantial gains toward diversity and net-zero emission goals in second annual ESG report

PR Newswire associated0

Revolutionizing Heart Health: Frontier X Plus Gains FDA Clearance

PR Newswire associated0

Clario presents a three-part webinar series on oncology trial solutions

PR Newswire associated0

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

PR Newswire associated0

Clario announces acquisition of AI-powered software company ArtiQ

PR Newswire associated0

Clario publishes third annual ESG Report, reaffirms commitment to ethical AI, workforce investment, and sustainability targets

AliveCor's KardiaMobile® 6L Becomes First Personal ECG Device Recommended for Use in Psychiatric Services in England and Wales